Foresite Capital Management Iv, LLC Orchard Therapeutics PLC Transaction History

Foresite Capital Management Iv, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$10.15 - $15.58 $5.66 Million - $8.69 Million	-557,700 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$11.88 - $16.72 $6.63 Million - $9.32 Million	557,700 New	557,700 $6.63 Million
Q1 2019 May 14, 2019	SELL	$12.01 - $19.49 $8.03 Million - $13 Million	-668,361 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$12.4 - $18.7 $8.29 Million - $12.5 Million	668,361 New	668,361 $10.5 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.